These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26977157)

  • 1. Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets.
    Codrici E; Enciu AM; Popescu ID; Mihai S; Tanase C
    Stem Cells Int; 2016; 2016():5728438. PubMed ID: 26977157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
    Filatova A; Acker T; Garvalov BK
    Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
    Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments.
    Taga T; Tabu K
    Inflamm Regen; 2020; 40():33. PubMed ID: 32952746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
    Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
    Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells.
    Bayin NS; Frenster JD; Sen R; Si S; Modrek AS; Galifianakis N; Dolgalev I; Ortenzi V; Illa-Bochaca I; Khahera A; Serrano J; Chiriboga L; Zagzag D; Golfinos JG; Doyle W; Tsirigos A; Heguy A; Chesler M; Barcellos-Hoff MH; Snuderl M; Placantonakis DG
    Oncotarget; 2017 Sep; 8(39):64932-64953. PubMed ID: 29029402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer ego-system in glioma: an iron-replenishing niche network systemically self-organized by cancer stem cells.
    Tabu K; Taga T
    Inflamm Regen; 2022 Nov; 42(1):54. PubMed ID: 36451253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHHC protein family targets different subsets of glioma stem cells in specific niches.
    Chen X; Hu L; Yang H; Ma H; Ye K; Zhao C; Zhao Z; Dai H; Wang H; Fang Z
    J Exp Clin Cancer Res; 2019 Jan; 38(1):25. PubMed ID: 30658672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New horizons in tumor microenvironment biology: challenges and opportunities.
    Chen F; Zhuang X; Lin L; Yu P; Wang Y; Shi Y; Hu G; Sun Y
    BMC Med; 2015 Mar; 13():45. PubMed ID: 25857315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain gliomas and growth factors: immunohistochemical, immunofluorescence, flow cytometry and RT-PCR profile in pediatric age.
    Taurone S; Spoletini M; Chiappetta C; Di Gioia C; Carletti R; Greco A; Agostinelli E; Ralli M; Giangaspero F; Artico M; Pastore FS; Scarpa S; Gobbi P; Di Liddo R
    J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1451-1463. PubMed ID: 31507151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
    Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
    Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma stem cells and immunotherapy for the treatment of malignant gliomas.
    Toda M
    ISRN Oncol; 2013; 2013():673793. PubMed ID: 23762610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.
    Ho IAW; Shim WSN
    Biomed Res Int; 2017; 2017():9634172. PubMed ID: 28630875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche.
    Diksin M; Smith SJ; Rahman R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting glioma stem cells: enough to terminate gliomagenesis?
    Dong J; Huang Q
    Chin Med J (Engl); 2011 Sep; 124(17):2756-63. PubMed ID: 22040437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.